Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GABA agonists and gabapentin for spastic hypertonia.

G E Francisco1, S Kothari, C Huls

  • 1Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, University of Texas Sciences Center, Brain Injury Program, Institute for Rehabilitation and Research, Houston, Texas, USA.

Physical Medicine and Rehabilitation Clinics of North America
|November 29, 2001
PubMed
Summary

Spasticity arises from disrupted nerve pathways in the central nervous system. Pharmacologic treatments target inhibitory mechanisms, like gamma-aminobutyric acid (GABA), to manage spasticity effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The challenge of phasing-out fossil fuel finance in the banking sector.

Nature communications·2024
Same author

The LDL receptor binding domain of apolipoprotein E directs the relative orientation of its C-terminal segment in reconstituted nascent HDL.

Biochimica et biophysica acta. Biomembranes·2021
Same author

Safety assessment of a standardized cucumber extract (Q-Actin<sup>™</sup>): Oral repeat-dose toxicity and mutagenicity studies.

Toxicology reports·2018
Same author

In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR.

Acta virologica·2018
Same author

Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study.

European journal of cancer care·2017
Same author

Exploration of Genomic, Proteomic, and Histopathological Image Data Integration Methods for Clinical Prediction.

IEEE China Summit & International Conference on Signal and Information Processing. IEEE China Summit & International Conference on Signal and Information Processing·2017

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Spasticity results from an imbalance in central nervous system pathways after injury.
  • This imbalance involves excitatory and inhibitory neural signaling.

Purpose of the Study:

  • To explore the pharmacologic control of spasticity.
  • To investigate the role of inhibitory neurotransmitter systems in spasticity management.

Main Methods:

  • Review of neuropharmacological mechanisms underlying spasticity.
  • Analysis of drug targets within inhibitory pathways.

Main Results:

  • Pharmacologic control of spasticity is achieved by antagonizing inhibitory mechanisms.
  • Gamma-aminobutyric acid (GABA) and glycine are key neurotransmitters involved.

Related Experiment Videos

Conclusions:

  • Targeting GABA receptor sites, which are widespread in the central nervous system, offers a viable strategy for pharmacologic manipulation.
  • Understanding these pathways is crucial for developing effective spasticity treatments.